Literature DB >> 8460122

Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of the protooncogene bcl-2.

G Deng1, E R Podack.   

Abstract

Absence of interleukin 2 (IL-2) from IL-2-dependent cells, such as the cytotoxic T-cell line CTLL2, causes DNA fragmentation and programmed cell death (apoptosis). We found that, upon initiation, DNA degradation proceeds rapidly. IL-2-deprived CTLL2 cells can be rescued from apoptosis by the addition of IL-2 2 h prior to the onset of detectable DNA breakdown. Addition of inhibitors of transcription with IL-2 abolished the IL-2-mediated rescue of CTLL2 cells. Thus it appears that IL-2-mediated gene transcription is necessary for survival. Deregulated expression of a protooncogene, bcl-2, inhibits apoptosis of cells dependent on other hematopoietic growth factors. To determine whether bcl-2 was active in CTLL2 cells, we transfected CTLL2 cells with a plasmid containing bcl-2 cDNA expressed under the metallothionein promoter and observed prolonged survival of the transfected cells upon IL-2 deprivation. Cell growth, however, was arrested in the G0/G1 or G2/M phases of the cell cycle. The prolonged survival of bcl-2 transfectants allowed the analysis of endogenous bcl-2 mRNA levels by Northern blot analysis. The expression of endogenous bcl-2 was down-regulated within 8 h of IL-2 withdrawal and was not detected after 3 days. Addition of IL-2 induced endogenous bcl-2 expression within 8 h. Full recovery of bcl-2 expression was achieved by 24 h after IL-2 addition. We conclude that the survival of death-prone CTLL2 cells may be viewed as IL-2-dependent suppression of suicide, probably by the IL-2-induced expression of the cellular bcl-2 gene.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8460122      PMCID: PMC46051          DOI: 10.1073/pnas.90.6.2189

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

Review 1.  Cell death during development of the nervous system.

Authors:  R W Oppenheim
Journal:  Annu Rev Neurosci       Date:  1991       Impact factor: 12.449

2.  Calcium-dependent killing of immature thymocytes by stimulation via the CD3/T cell receptor complex.

Authors:  D J McConkey; P Hartzell; J F Amador-Pérez; S Orrenius; M Jondal
Journal:  J Immunol       Date:  1989-09-15       Impact factor: 5.422

3.  Induction of apoptosis in fibroblasts by c-myc protein.

Authors:  G I Evan; A H Wyllie; C S Gilbert; T D Littlewood; H Land; M Brooks; C M Waters; L Z Penn; D C Hancock
Journal:  Cell       Date:  1992-04-03       Impact factor: 41.582

4.  BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.

Authors:  D M Hockenbery; M Zutter; W Hickey; M Nahm; S J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

5.  bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship.

Authors:  A Strasser; A W Harris; S Cory
Journal:  Cell       Date:  1991-11-29       Impact factor: 41.582

6.  Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines.

Authors:  G Nuñez; L London; D Hockenbery; M Alexander; J P McKearn; S J Korsmeyer
Journal:  J Immunol       Date:  1990-05-01       Impact factor: 5.422

7.  Activation-driven T cell death. I. Requirements for de novo transcription and translation and association with genome fragmentation.

Authors:  D S Ucker; J D Ashwell; G Nickas
Journal:  J Immunol       Date:  1989-12-01       Impact factor: 5.422

8.  Caenorhabditis elegans gene ced-9 protects cells from programmed cell death.

Authors:  M O Hengartner; R E Ellis; H R Horvitz
Journal:  Nature       Date:  1992-04-09       Impact factor: 49.962

9.  Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death.

Authors:  D Hockenbery; G Nuñez; C Milliman; R D Schreiber; S J Korsmeyer
Journal:  Nature       Date:  1990-11-22       Impact factor: 49.962

10.  bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes.

Authors:  C L Sentman; J R Shutter; D Hockenbery; O Kanagawa; S J Korsmeyer
Journal:  Cell       Date:  1991-11-29       Impact factor: 41.582

View more
  37 in total

1.  Expression of Bcl-2 in inflammatory sites from patients with active Behçet's disease.

Authors:  K Hamzaoui; A Hamzaoui; L Zakraoui; A Chabbou
Journal:  Mediators Inflamm       Date:  1999       Impact factor: 4.711

2.  Interleukin 12 stimulates IFN-gamma-mediated inhibition of tumor-induced regulatory T-cell proliferation and enhances tumor clearance.

Authors:  Xuefang Cao; Karen Leonard; Lynne I Collins; Sheng F Cai; Joshua C Mayer; Jacqueline E Payton; Michael J Walter; David Piwnica-Worms; Robert D Schreiber; Timothy J Ley
Journal:  Cancer Res       Date:  2009-10-20       Impact factor: 12.701

3.  Functional cleavage of the common cytokine receptor gamma chain (gammac) by calpain.

Authors:  M Noguchi; A Sarin; M J Aman; H Nakajima; E W Shores; P A Henkart; W J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

4.  Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo.

Authors:  R Agah; L A Kirshenbaum; M Abdellatif; L D Truong; S Chakraborty; L H Michael; M D Schneider
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

5.  A new immunosuppressant, FTY720, induces bcl-2-associated apoptotic cell death in human lymphocytes.

Authors:  S Suzuki; X K Li; S Enosawa; T Shinomiya
Journal:  Immunology       Date:  1996-12       Impact factor: 7.397

Review 6.  Dying to protect: cell death and the control of T-cell homeostasis.

Authors:  Kun-Po Li; Sharmila Shanmuganad; Kaitlin Carroll; Jonathan D Katz; Michael B Jordan; David A Hildeman
Journal:  Immunol Rev       Date:  2017-05       Impact factor: 12.988

Review 7.  Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 family.

Authors:  Hélène Bour-Jordan; Jonathan H Esensten; Marc Martinez-Llordella; Cristina Penaranda; Melanie Stumpf; Jeffrey A Bluestone
Journal:  Immunol Rev       Date:  2011-05       Impact factor: 12.988

8.  Characterization of a mast cell line that lacks the extracellular domain of membrane c-kit.

Authors:  Y A Mekori; C K Oh; J Dastych; J P Goff; S Adachi; P J Bianchine; A Worobec; T Semere; J H Pierce; D D Metcalfe
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

9.  Apoptosis and Bcl-2 expression in cultured murine splenic T cells.

Authors:  H E Broome; C M Dargan; E F Bessent; S Krajewski; J C Reed
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

10.  PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells.

Authors:  Erin E West; Hyun-Tak Jin; Ata-Ur Rasheed; Pablo Penaloza-Macmaster; Sang-Jun Ha; Wendy G Tan; Ben Youngblood; Gordon J Freeman; Kendall A Smith; Rafi Ahmed
Journal:  J Clin Invest       Date:  2013-05-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.